Souma J A, Green P J, Coppage A T, Donner R S, Hogg A L
South Med J. 1981 Jun;74(6):684-7. doi: 10.1097/00007611-198106000-00013.
We measured T4, T3, T3 uptake, and TSH in nonpregnant patients, pregnant patients in the early and late first, and third trimesters, and patients using oral contraceptives. Mean T4 levels increased and T3 uptake decreased during pregnancy. Concentrations of T3 decreased in early pregnancy, then increased during the rest of pregnancy. Thyroid-stimulating hormone (TSH) values were elevated in the second trimester. Decreased T3 concentration in the early first trimester suggests increased use of T3 by the fetus, placenta, and/or mother not compensated for by increased T4 pool size. Values found in oral contraceptive users were similar to those found in early pregnancy and may reflect changes in response to levels of estrogen found in oral contraceptives. Values provided illustrate changes in thyroid function parameters and are useful in providing a target range of laboratory values for therapeutic manipulation when comparing thyroid function values in nonpregnant patients, pregnant patients, and those using oral contraceptives.
我们测量了未怀孕患者、孕早期和孕晚期以及孕中期的孕妇和使用口服避孕药患者的甲状腺素(T4)、三碘甲状腺原氨酸(T3)、T3摄取率和促甲状腺激素(TSH)。孕期T4平均水平升高,T3摄取率降低。孕早期T3浓度降低,随后在孕期其余阶段升高。孕中期促甲状腺激素(TSH)值升高。孕早期T3浓度降低表明胎儿、胎盘和/或母体对T3的利用增加,而T4储备量增加无法补偿这一情况。口服避孕药使用者的检测值与孕早期相似,可能反映了对口服避孕药中雌激素水平变化的反应。所提供的值说明了甲状腺功能参数的变化,在比较未怀孕患者、孕妇和使用口服避孕药患者的甲状腺功能值时,有助于为治疗操作提供实验室值的目标范围。